litlas
Log inCreate account

Naga Chalasani

Active 1995–2025

277
Papers
56,068
Citations
112
h-index
254
i10-index

Citations

Citations per year for Naga Chalasani1986: 1 citations1993: 1 citations1994: 1 citations1996: 1 citations1997: 2 citations1998: 8 citations1999: 11 citations2000: 14 citations2001: 27 citations2002: 21 citations2003: 48 citations2004: 55 citations2005: 102 citations2006: 113 citations2007: 104 citations2008: 120 citations2009: 168 citations2010: 236 citations2011: 260 citations2012: 306 citations2013: 427 citations2014: 490 citations2015: 612 citations2016: 627 citations2017: 608 citations2018: 626 citations2019: 2,265 citations2020: 2,562 citations2021: 2,695 citations2022: 2,433 citations2023: 1,938 citations2024: 2,971 citations2025: 1,493 citations2026: 65 citations1987–1992: no citations, so these years are not shown1995: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,392 citing papers, 23.1% of this breakdownChina: 3,016 citing papers, 12.9% of this breakdownUnited Kingdom: 1,455 citing papers, 6.3% of this breakdownItaly: 1,352 citing papers, 5.8% of this breakdownGermany: 953 citing papers, 4.1% of this breakdownSpain: 818 citing papers, 3.5% of this breakdownJapan: 744 citing papers, 3.2% of this breakdownFrance: 726 citing papers, 3.1% of this breakdownSouth Korea: 659 citing papers, 2.8% of this breakdownCanada: 588 citing papers, 2.5% of this breakdownAustralia: 490 citing papers, 2.1% of this breakdownIndia: 461 citing papers, 2% of this breakdown
0%23.1%Other 28.6%

Institutions

Fields

  • Medicine80.5%
  • Biochemistry, Genetics and Molecular Biology8.4%
  • Pharmacology, Toxicology and Pharmaceutics5.9%
  • Immunology and Microbiology1.3%
  • Computer Science0.7%
  • Nursing0.6%
  • Other2.6%

Topics

  • Liver Disease Diagnosis and Treatment22.4%
  • Liver Disease and Transplantation7%
  • Diet, Metabolism, and Disease5.1%
  • Liver Diseases and Immunity3.5%
  • Alcohol Consumption and Health Effects3%
  • Diabetes, Cardiovascular Risks, and Lipoproteins2.9%
  • Other56.1%

Coauthors

All papers

Open in search
  1. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

    Authors: Naga Chalasani, Zobair M. Younossi, Joel E. Lavine, Michael Charlton, Kenneth Cusi, Mary E. Rinella, Stephen A. Harrison, Elizabeth M. Brunt, Arun J. Sanyal - Hepatology 2017 cited by 7,293

  2. Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

    Authors: Arun J. Sanyal, Mark L. Van Natta, Jeanne M. Clark, Brent A. Neuschwander‐Tetri, Anna‐Mae Diehl, Srinivasan Dasarathy, Rohit Loomba, Naga Chalasani, Kris V. Kowdley, Bilal Hameed, Laura Wilson, Katherine P. Yates, Patricia Belt, Mariana Lazo, David E. Kleiner, Cynthia Behling, James Tonascia - New England Journal of Medicine 2021 cited by 1,065

  3. Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

    Authors: Arun J. Sanyal, Naga Chalasani, Kris V. Kowdley, Arthur J. McCullough, Anna Mae Diehl, Nathan M. Bass, Brent A. Neuschwander‐Tetri, Joel E. Lavine, James Tonascia, Aynur Ünalp, Mark L. Van Natta, Jeanne M. Clark, Elizabeth M. Brunt, David E. Kleiner, Jay H. Hoofnagle, Patricia R. Robuck - New England Journal of Medicine 2010 cited by 3,297

  4. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

    Authors: Brent A. Neuschwander‐Tetri, Rohit Loomba, Arun J. Sanyal, Joel E. Lavine, Mark L. Van Natta, Manal F. Abdelmalek, Naga Chalasani, Srinivasan Dasarathy, Anna Mae Diehl, Bilal Hameed, Kris V. Kowdley, Arthur J. McCullough, Norah A. Terrault, Jeanne M. Clark, James Tonascia, Elizabeth M. Brunt, David E. Kleiner, Edward Doo - The Lancet 2014 cited by 2,185

  5. Drug-induced liver injury

    Authors: Raúl J. Andrade, Naga Chalasani, Einar S. Björnsson, Ayako Suzuki, Gerd A. Kullak‐Ublick, Paul B. Watkins, Harshad Devarbhavi, Michael Merz, M. Isabel Lucena, Neil Kaplowitz, Guruprasad P. Aithal - Nature Reviews Disease Primers 2019 cited by 801

  6. Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease

    Authors: Mohammad Shadab Siddiqui, Raj Vuppalanchi, Mark L. Van Natta, Erin Hallinan, Kris V. Kowdley, Manal F. Abdelmalek, Brent A. Neuschwander‐Tetri, Rohit Loomba, Srinivasan Dasarathy, Danielle Brandman, Edward Doo, James Tonascia, David E. Kleiner, Naga Chalasani, Arun J. Sanyal - Clinical Gastroenterology and Hepatology 2018 cited by 594

  7. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

    Authors: Naga Chalasani, Zobair M. Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal - Hepatology 2012 cited by 3,823

  8. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study

    Authors: Eduardo Vilar‐Gómez, Luis Calzadilla Bertot, Vincent Wai‐Sun Wong, Marlén Castellanos, Rocio Aller‐de la Fuente, Mayada Metwally, Mohammed Eslam, Licet Gonzalez‐Fabian, María Álvarez-Quiñones Sanz, Antonio Félix Conde-Martín, Bastiaan de Boer, Duncan McLeod, Anthony W.H. Chan, Naga Chalasani, Jacob George, Leon A. Adams, Manuel Romero‐Gómez - Gastroenterology 2018 cited by 792

  9. Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double‐Blind Phase 2 Trial

    Authors: Samer Gawrieh, Mazen Noureddin, Nicole Loo, Rizwana Mohseni, Vivek Awasty, Kenneth Cusi, Kris V. Kowdley, Michelle Lai, Eugene R. Schiff, Dhruvanshu Parmar, Pankaj Patel, Naga Chalasani - Hepatology 2021 cited by 356

  10. High‐quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population

    Authors: Eduardo Vilar‐Gómez, Lauren Nephew, Raj Vuppalanchi, Samer Gawrieh, Andrea Mladenovic, Francis Pike, Niharika Samala, Naga Chalasani - Hepatology 2021 cited by 288

  11. Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study

    Authors: Daniel Q. Huang, Laura Wilson, Cynthia Behling, David E. Kleiner, Kris V. Kowdley, Srinivasan Dasarathy, Maral Amangurbanova, Norah A. Terrault, Anna Mae Diehl, Naga Chalasani, Brent A. Neuschwander‐Tetri, Arun J. Sanyal, James Tonascia, Daniela Allende, Annette Bellar, Jaividhya Dasarathy, Srinivasan Dasarathy, Nicole Welch, Rahul Yerrapothu, Mustafa R. Bashir, Anna Mae Diehl, Cynthia D. Guy, Mariko Kopping, Dawn Piercy, Ayako Suzuki, Naglaa Tawadrou, Naga Chalasani, Mandy Cruz, Oscar W. Cummings, Lisa Garrison, Samer Gawrieh, Niharika Samala, Raj Vuppalanchi, Danielle Carpenter, Theresa Cattoor, Janet Freebersyser, Brent A. Neuschwander‐Tetri, Pannapat Angkanaworakul, Achashman Berihun, Andrew Buysse, Theresa Dorrian, Breanna Gulati, Kris V. Kowdley, Kevin Liu, S Misić, Adam Sohal, J. Vuong, Veeral Ajmera, Cynthia Behling, Rohit Loomba, Egbert Madamba, Michael S. Middleton, Lisa Richards, Seema Singh, Claude B. Sirlin, Ryan M. Gill, Bilal Hameed, Remilekun Awe, Daisy Rios Olvera, Norah A. Terrault, Liyun Yuan, Matthew M. Yeh, Somaya Albhaisi, Amon Asgharpour, Sherry Boyett, Melissa J. Contos, Velimir A. Luketic, Arun J. Sanyal, Jolene Schlosser, Mohammad Shadab Siddiqui, David E. Kleiner, Peggy Adamo, Patricia Belt, Jeanne M. Clark, Jennifer DeSanto, Jill Meinert, Laura Miriel, Emily Mitchell, Carrie Shade, Jacqueline Smith, Michael L. Smith, Alice Sternberg, James Tonascia, Mark L. Van Natta, Annette Wagoner, Laura A. Wilson, Tinsay A. Woreta, Katherine P. Yates, Rohit Loomba - Gastroenterology 2023 cited by 167

  12. Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study

    Authors: Naga Chalasani, Herbert L. Bonkovsky, Robert J. Fontana, William Lee, Andrew Stolz, Jayant A. Talwalkar, K. Rajendar Reddy, Paul B. Watkins, Victor J. Navarro, Huiman X. Barnhart, Jiezhun Gu, José Serrano, Jawad Ahmad, Nancy Bach, Meena B. Bansal, Huiman X. Barnhart, Kimberly L. Beavers, Herbert L. Bonkovsky, Francisco O. Calvo, Naga Chalasani, Charissa Chang, Hari S. Conjeevaram, Gregory E. Conner, Jama M. Darling, Ynto S. de Boer, Douglas T. Dieterich, Frank DiPaola, Francisco Durazo, James E. Everhart, Robert J. Fontana, Marwan Ghabril, David S. Goldstein, Vani Gopalreddy, Priya Grewal, Paul H. Hayashi, Jay H. Hoofnagle, Neil Kaplowitz, Suthat Liangpunsakul, Steven N. Lichtman, Lawrence Liu, Victor J. Navarro, Joseph A. Odin, Simona Rossi, Mark W. Russo, Thomas D. Schiano, José Serrano, Averell H. Sherker, Andrew Stolz, Raj Vuppalanchi, Paul B. Watkins, Steven Zacks, Amanda Balasco, Kristin Chesney, Audrey Corne, Sherrie Cummings, Gale Groseclose, Alex Hammett, Judy Hooker, Varun Kesar, Sophana Mao, Kenari Marks, R. Bruce McFadden, Yolanda Melgoza, Sherif Mikhail, Susan L Milstein, Wendy Morlan, Val Peacock, Nidia Rosado, Tracy Russell, Maricruz Vega, Manisha Verma, Patricia Walker, Rachana Yalamanchili, Michelle McClanahan-Crowder, Katherine Galan, Jiezhun Gu, Tuan Chau, Kowsalya Ragavan, Hoss Rostami, Carmel Puglisi-Scharenbroich, Rebecca Torrance, Rebekah Van Raaphorst - Gastroenterology 2015 cited by 899

  13. Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension

    Authors: Naga Chalasani, Manal F. Abdelmalek, Guadalupe García–Tsao, Raj Vuppalanchi, Naim Alkhouri, Mary E. Rinella, Mazen Noureddin, Maxmillan Pyko, Mitchell L. Shiffman, Arun J. Sanyal, Adam Allgood, Harold Shlevin, R. G. Horton, Eliezer Zomer, William Irish, Zachary Goodman, Stephen A. Harrison, Peter G. Traber, Manal F. Abdelmalek, Luis A. Balart, Brian B. Borg, Naga Chalasani, Michael Charlton, Hari S. Conjeevaram, Michael Fuchs, Reem Ghalib, Pierre Gholam, Dina Halegoua‐De Marzio, Stephen A. Harrison, Christopher Jue, Nyingi Kemmer, Kris V. Kowdley, Michelle Lai, Eric Lawitz, Rohit Loomba, Mazen Noureddin, Angelo H. Paredes, Mary E. Rinella, Don C. Rockey, Miguel Rodriguez, Raymond A. Rubin, Michael Ryan, Arun J. Sanyal, Andrew Scanga, Thomas Sepe, Mitchell L. Shiffman, Mitchell L. Shiffman, Brent Tetri, Paul J. Thuluvath, Dawn M. Torres, John M. Vierling, Julia Wattacheril, Amanda Weiland, Donald L. Zogg - Gastroenterology 2019 cited by 344

  14. Nonalcoholic Fatty Liver Disease and the Heart

    Authors: Eric Stahl, Devinder S. Dhindsa, Suegene Lee, Pratik B. Sandesara, Naga Chalasani, Laurence Sperling - Journal of the American College of Cardiology 2019 cited by 424

  15. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

    Authors: Naga Chalasani, Zobair M. Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal - Gastroenterology 2012 cited by 1,774

  16. Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease

    Authors: David E. Kleiner, Elizabeth M. Brunt, Laura Wilson, Cynthia Behling, Cynthia D. Guy, Melissa J. Contos, Oscar W. Cummings, Matthew M. Yeh, Ryan M. Gill, Naga Chalasani, Brent A. Neuschwander‐Tetri, Anna Mae Diehl, Srinivasan Dasarathy, Norah A. Terrault, Kris V. Kowdley, Rohit Loomba, Patricia Belt, James Tonascia, Joel E. Lavine, Arun J. Sanyal - JAMA Network Open 2019 cited by 367

  17. ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury

    Authors: Naga Chalasani, Haripriya Maddur, Mark W. Russo, Robert J. Wong, K. Rajender Reddy - The American Journal of Gastroenterology 2021 cited by 372

  18. A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation

    Authors: Marijana Vujković, Shweta Ramdas, Kimberly Lorenz, Xiuqing Guo, Rebecca Darlay, Heather J. Cordell, Jing He, Yevgeniy Gindin, Chuhan Chung, Robert P. Myers, Carolin V. Schneider, Joseph Park, Kyung Min Lee, Marina Serper, Rotonya M. Carr, David E. Kaplan, Mary E. Haas, Matthew T. MacLean, Walter R. Witschey, Xiang Zhu, Catherine Tcheandjieu, Rachel L. Kember, Henry R. Kranzler, Anurag Verma, Ayush Giri, Derek Klarin, Yan V. Sun, Jie Huang, Jennifer E. Huffman, Kate Townsend Creasy, Nicholas J. Hand, Ching‐Ti Liu, Michelle T. Long, Jie Yao, Matthew J. Budoff, Jingyi Tan, Xiaohui Li, Henry J. Lin, Yii‐Der Ida Chen, Kent D. Taylor, Ruey‐Kang R. Chang, Ronald M. Krauss, Sílvia Vilarinho, Joseph Brancale, Jonas B. Nielsen, Adam E. Locke, Marcus B. Jones, Niek Verweij, Aris Baras, K. Rajender Reddy, Brent A. Neuschwander‐Tetri, Jeffrey B. Schwimmer, Arun J. Sanyal, Naga Chalasani, Kathleen A. Ryan, Braxton D. Mitchell, Dipender Gill, Andrew D. Wells, Elisabetta Manduchi, Yedidya Saiman, Nadim Mahmud, Donald R. Miller, Peter D. Reaven, Lawrence S. Phillips, Sumitra Muralidhar, Scott L. DuVall, Jennifer Lee, Themistocles L. Assimes, Saiju Pyarajan, Kelly Cho, Todd L. Edwards, Scott M. Damrauer, Peter W.F. Wilson, J. Michael Gaziano, Christopher J. O’Donnell, Amit V. Khera, Struan F.A. Grant, Christopher D. Brown, Philip S. Tsao, Danish Saleheen, Luca A. Lotta, Lisa Bastarache, Quentin M. Anstee, Ann K. Daly, James B. Meigs, Jerome I. Rotter, Julie A. Lynch, VA Million Veteran Program, Daniel J. Rader, Benjamin F. Voight, Kyong‐Mi Chang - Nature Genetics 2022 cited by 194

  19. Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers

    Authors: Eduardo Vilar‐Gómez, Naga Chalasani - Journal of Hepatology 2017 cited by 616

  20. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage

    Authors: Mohammad Shadab Siddiqui, Goro Yamada, Raj Vuppalanchi, Mark L. Van Natta, Rohit Loomba, Cynthia D. Guy, Danielle Brandman, James Tonascia, Naga Chalasani, Brent A. Neuschwander‐Tetri, Arun J. Sanyal, Daniela Allende, Srinivasan Dasarathy, Arthur J. McCullough, Revathi Penumatsa, Jaividhya Dasarathy, Joel E. Lavine, Manal F. Abdelmalek, Mustafa R. Bashir, Stephanie Buie, Anna Mae Diehl, Cynthia D. Guy, Christopher Kigongo, Mariko Kopping, David Malik, Dawn Piercy, Naga Chalasani, Oscar W. Cummings, Samer Gawrieh, Linda Ragozzino, Kumar Sandrasegaran, Raj Vuppalanchi, Elizabeth M. Brunt, Theresa Cattoor, Danielle Carpenter, Janet Freebersyser, Debra King, Jinping Lai, Brent A. Neuschwander‐Tetri, Joan Siegner, Susan L. Stewart, Susan Torretta, Kristina Wriston, Maria Cardona Gonzalez, Jodie Davila, Manan Jhaveri, Kris V. Kowdley, Nizar A. Mukhtar, Erik Ness, Michelle Poitevin, Brook A. Quist, Sherilynn Soo, Brandon Ang, Cynthia Behling, Archana Bhatt, Rohit Loomba, Michael S. Middleton, Claude B. Sirlin, Maheen F. Akhter, Nathan M. Bass, Danielle Brandman, Ryan M. Gill, Bilal Hameed, Jacqueline Maher, Norah A. Terrault, Ashley Ungermann, Matthew M. Yeh, Sherry Boyett, Melissa J. Contos, S. Kirwin, Velimir A. Luketic, Puneet Puri, Arun J. Sanyal, Jolene Schlosser, Mohammad Shadab Siddiqui, Leslie Yost-Schomer, Elizabeth M. Brunt, Kathryn J. Fowler, David E. Kleiner, Edward Doo, Sherry Hall, Jay H. Hoofnagle, Jessica J. Lee, Patricia R. Robuck, Averell H. Sherker, Rebecca Torrance, Patricia Belt, Jeanne M. Clark, J.A. Dodge, Michele Donithan, Erin Hallinan, Milana Isaacson, Mariana Lazo, Jill Meinert, Laura Miriel, Jacqueline Smith, Michael L. Smith, Alice Sternberg, James Tonascia, Mark L. Van Natta and 4 more - Clinical Gastroenterology and Hepatology 2019 cited by 268

  21. Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia

    Authors: David W. Crabb, Ramón Bataller, Naga Chalasani, Patrick S. Kamath, Michael R. Lucey, Philippe Mathurin, Craig J. McClain, Arthur J. McCullough, Mack C. Mitchell, Timothy R. Morgan, Laura E. Nagy, Svetlana Radaeva, Arun J. Sanyal, Vijay H. Shah, Gyöngyi Szabó - Gastroenterology 2016 cited by 535

  22. An Open‐Label, Dose‐Escalation Study to Assess the Safety and Efficacy of IL‐22 Agonist F‐652 in Patients With Alcohol‐associated Hepatitis

    Authors: Juan Pablo Arab, Tejasav S. Sehrawat, Douglas A. Simonetto, Vikas Verma, Dechun Feng, Tom Tang, Kevin Dreyer, Xiaoqiang Yan, William Daley, Arun J. Sanyal, Naga Chalasani, Svetlana Radaeva, Liu Yang, Hugo E. Vargas, Mauricio Ibacache, Bin Gao, Gregory J. Gores, Harmeet Malhi, Patrick S. Kamath, Vijay H. Shah - Hepatology 2019 cited by 203

  23. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

    Authors: Sun‐Gou Ji, The International PSC Study Group, Brian D. Juran, Sören Mucha, Trine Folseraas, Luke Jostins, Espen Melum, Natsuhiko Kumasaka, Elizabeth J. Atkinson, Erik M. Schlicht, Jimmy Z. Liu, Tejas Shah, Javier Gutierrez‐Achury, Kirsten Muri Boberg, Annika Bergquist, Séverine Vermeire, Bertus Eksteen, Peter R. Durie, Martti Färkkilâ, Tobias Müller, Christoph Schramm, Martina Sterneck, Tobias J. Weismüller, Daniel Gotthardt, David Ellinghaus, Felix Braun, Andreas Teufel, Mattias Laudes, Wolfgang Lieb, Gunnar Jacobs, Ulrich Beuers, Rinse K. Weersma, Cisca Wijmenga, Hanns–Ulrich Marschall, Piotr Milkiewicz, Albert Parés, Kimmo Kontula, Olivier Chazouillères, Pietro Invernizzi, Elizabeth C. Goode, Kelly Spiess, Carmel Moore, Jennifer Sambrook, Willem H. Ouwehand, David J. Roberts, John Danesh, Annarosa Floreani, Aliya Gulamhusein, John E. Eaton, Stefan Schreiber, Catalina Coltescu, Christopher L. Bowlus, Velimir A. Luketic, Joseph A. Odin, Kapil Chopra, Kris V. Kowdley, Naga Chalasani, Michael P. Manns, Brijesh Srivastava, George Mells, Richard Sandford, Graeme Alexander, Daniel J. Gaffney, Roger W. Chapman, Gideon M. Hirschfield, Mariza de Andrade, Simon Rushbrook, André Franke, Tom H. Karlsen, Konstantinos N. Lazaridis, Carl A. Anderson - Nature Genetics 2016 cited by 382

  24. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report

    Authors: Raúl J. Andrade, Guruprasad P. Aithal, Ynto S. de Boer, Rodrigo Liberal, Alexander L. Gerbes, Arie Regev, Benedetta Terziroli Beretta‐Piccoli, Christoph Schramm, David E. Kleiner, Eléonora De Martin, Gerd A. Kullak‐Ublick, Guido Stirnimann, Harshad Devarbhavi, John M. Vierling, Michael P. Manns, Marcial Sebode, María‐Carlota Londoño, Mark Avigan, Mercedes Robles‐Díaz, Miren García‐Cortés, Edmond Atallah, Michael Heneghan, Naga Chalasani, Palak Trivedi, Paul H. Hayashi, Richard Taubert, Robert J. Fontana, Sabine Weber, Ye Htun Oo, Yoh Zen, Anna Licata, M. Isabel Lucena, Giorgina Mieli‐Vergani, Diego Vergani, Einar S. Björnsson - Journal of Hepatology 2023 cited by 150